Influenza Transmission Research Consortium (P01 Clinical Trial Optional)

The Influenza Transmission Research Consortium (P01 Clinical Trial Optional) is a forecasted funding opportunity supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. This initiative seeks to foster a deeper understanding of the mechanisms behind human-to-human transmission of seasonal influenza. The consortium will support the development of a network of research centers that conduct collaborative, multidisciplinary investigations into the dynamics and determinants of influenza transmission. This initiative aligns with NIAID’s broader mission to support research that improves public health by advancing knowledge of infectious and immunologic diseases. The centers funded under this program will be expected to develop and apply novel methodologies and resources to expand the scientific understanding of respiratory virus transmission, contributing significantly to influenza prevention and control strategies. The opportunity is forecasted with an estimated application opening date of September 8, 2025, and an application due date of November 7, 2025. The estimated award date and project start date are both set for July 1, 2026. A total program funding of $8,000,000 is anticipated, with three awards expected. There are no defined award ceiling or floor limits noted at this time. Cost sharing or matching is not required for this funding opportunity. Eligible applicants span a wide range of organizations including independent school districts, county governments, small businesses, public and private higher education institutions, nonprofits with 501(c)(3) status (excluding higher education institutions), public housing authorities, and tribal organizations (both federally recognized and others). For-profit organizations other than small businesses, and state governments are also eligible to apply. Although applications are not currently being accepted, this notice is intended to give potential applicants sufficient time to prepare. Investigators with relevant expertise are encouraged to begin forming collaborative teams and planning responsive projects. The application will follow the P01 activity code, which supports multi-project research programs involving several independent investigators. Interested applicants should direct inquiries to Dr. Brooke Bozick at the National Institute of Allergy and Infectious Diseases. She can be reached via email at brooke.bozick@mail.nih.gov or by phone at 301-761-6710.

Applicants are encouraged to start forming collaborations and project plans in anticipation of the opportunity opening.